Daniel Liebler

Daniel Liebler has a diverse work experience spanning over several years. Daniel is currently serving as the Vice President of Proteomic Technology at Inotiv since July 2022. Previously, from January 2017 to July 2022, they held the positions of President and CEO at Protypia, Inc. Prior to that, from June 2003 to December 2016, they worked as a Professor of Biochemistry at Vanderbilt University School of Medicine. Daniel started their professional career as a Professor at the University of Arizona in 1987 and worked there until 2003.

Daniel Liebler has a Doctor of Philosophy (PhD) in Pharmacology from Vanderbilt University School of Medicine and a Bachelor of Science (BS) in Chemistry from Villanova University.